Categories: Medical Drug Safety
On May 31, 2017, Ohio Attorney General Mike DeWine filed a lawsuit against five leading prescription opioid manufacturers and their related companies, charging that the drug companies engaged in fraudulent marketing about the risks and benefits of prescription opioids, which misled patients and fueled Ohio’s opioid epidemic. Specifically, the lawsuit (State of Ohio ex rel....
Categories: Hernia Mesh Lawsuits
On June 2, 2017, the Judicial Panel on Multidistrict Litigation (JPML) created a new MDL for the federal lawsuits alleging injury caused by the synthetic hernia repair product, Physiomesh, filed against Ethicon and Johnson & Johnson. In the June 2nd order, the JPML ordered the transfer of the cases to the U.S. District Court for the Northern...
Categories: Talc Cancer Lawsuits
On Thursday, Johnson & Johnson was ordered by a Missouri jury to pay over $110 million to a Virginia woman, Lois Slemp, who says she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene. Specially, the lawsuit, (along with numerous others filed across the country), alleges that Johnson & Johnson...
Categories: Medical Device Safety
Yesterday, the FDA issued a safety alert warning of ReFlow Medical’s 4/22/17 lot-specific voluntary recall of its Wingman35 Crossing Catheters distributed between January 2015 and March 2016. According to the FDA, the Wingman35 Crossing Catheters have been found to exhibit tip splitting or separation, which has resulted in two adverse events. Tip splitting has the...
Categories: Hernia Mesh Lawsuits
On May 25, 2017 the Judicial Panel on Multidistrict Litigation (JPML) will hold a hearing on the motion filed by claimants/plaintiffs to create a new MDL for the Physiomesh Flexible Composite hernia mesh cases filed against Ethicon and Johnson & Johnson. A MDL is a type of legal proceeding that helps federal courts efficiently manage many...
Categories: Consumer Safety Alerts
The FDA recently issued a safety alert, along with warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer. These products include pills, topical creams, ointments, oils, drops, syrups, teas and diagnostics (such as thermography devices). The products are marketed and sold...
Categories: Xarelto Bleed Litigation
The first of four bellwether trials in the Xarelto® (rivaroxaban) multidistrict litigation in Louisiana Federal Court is currently underway. Plaintiff Joseph Boudreaux, 74, of Lockport, La., alleges that he developed gastrointestinal bleeding after he began taking Xarelto in 2014, requiring hospitalization, numerous blood transfusions and other serious treatments. As previously reported in this blog, this litigation...
Categories: Medical Drug Safety
Today, the FDA issued a drug safety communication that it has approved previously announced label changes regarding the use of general anesthetic and sedation medicines in children younger than 3 years. These changes include: A new Warning stating that exposure to these medicines for lengthy periods of time or over multiple surgeries or procedures may...
Categories: Patient Rights
When you visit your doctor, you are often asked to sign a “HIPAA” form that the receptionist often explains has to do with protecting privacy. However, many patients do not realize that the regulations under this important law also gives you, the patient, very important rights with respect to accessing your health information. The Health...
Categories: EpiPen Recall
On March 31, 2017, Mylan N.V. announced that Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner for EpiPen® Auto-Injector, expanded its recall of select lots of EpiPen (epinephrine injection, USP) and EpiPen Jr® (epinephrine injection, USP) Auto-Injectors to now include additional lots distributed in the U.S. and other markets. As reported in the...
Copyright ©2025 Borgess Law
Law Firm Web Design by Black Fin